abs171.txt	the	tam	(tyro-3		axl	mertk)	family	receptor	tyrosine	kinases	(rtks)	play	animportant	role	in	promoting	growth	survival	and	metastatic	spread	of	severaltumor	types	mertk	are	overexpressed	head	neck	squamous	cellcarcinoma	(hnscc)	triple-negative	breast	cancer	(tnbc)	non-small	cell	lungcancer	(nsclc)	malignancies	that	highly	lethal	is	themost	well-characterized	mediates	resistance	to	both	conventionaland	targeted	therapies	since	expressed	aggressive	tumortypes	patients	currently	being	enrolled	clinical	trials	testingaxl	inhibitors	current	study	we	analyzed	effects	inhibitionusing	a	small	molecule	inhibitor	monoclonal	antibody	therapy	sirna	inhnscc	tnbc	nsclc	preclinical	models	anti-axl	targeting	strategies	hadlimited	efficacy	across	these	different	which	our	data	suggests	could	beattributed	upregulation	expression	was	increased	linesand	patient-derived	xenografts	treated	with	inhibition	ofmertk	sensitized	hnscc	dual	led	more	potent	blockade	downstreamsignaling	synergistic	tumor	expansion	culture	reducedtumor	vivo	furthermore	ectopic	overexpression	axlinhibitor-sensitive	resulted	axl-targeting	observations	suggest	therapeutic	co-targeting	andmertk	be	beneficial	variety	where	receptorsare	leading	improved	for	lethalmalignancies
